1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine

C167H350FN27O10 — CID 159654799

IUPAC1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine
SMILESCC(C)(C)N1CC(O)C(O)C1.CC(C)(C)N1CC(O)C1.CC(C)(C)N1CC2CCC1C2.CC(C)(C)N1CCC(N)C1.CC(C)(C)N1CCC(N2CCOCC2)C1.CC(C)(C)N1CCC(NCCCF)C1.CC(C)(C)N1CCC(O)C1.CC(C)(C)N1CCC(O)CC1.CC(C)(C)N1CCC2CNCC21.CC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCN(C(=O)CC2CCCN2)CC1.CC1(O)CCN(C(C)(C)C)C1.CCCC1CCCN(C(C)(C)C)C1.CCNC1CCN(C(C)(C)C)C1.CN(C)C1CCN(C(C)(C)C)C1.CNC1CCN(C(C)(C)C)C1.COCCNC1CCN(C(C)(C)C)C1
InChIInChI=1S/C14H27N3O.C12H24N2O.C12H25N.C11H23FN2.C11H24N2O.C10H20N2.2C10H22N2.C10H19N.C9H20N2.3C9H19NO.C8H18N2.C8H17NO2.C8H17NO.C7H15NO/c1-14(2,3)17-9-7-16(8-10-17)13(18)11-12-5-4-6-15-12;1-12(2,3)14-5-4-11(10-14)13-6-8-15-9-7-13;1-5-7-11-8-6-9-13(10-11)12(2,3)4;1-11(2,3)14-8-5-10(9-14)13-7-4-6-12;1-11(2,3)13-7-5-10(9-13)12-6-8-14-4;1-10(2,3)12-5-4-8-6-11-7-9(8)12;1-10(2,3)12-7-6-9(8-12)11(4)5;1-5-11-9-6-7-12(8-9)10(2,3)4;1-10(2,3)11-7-8-4-5-9(11)6-8;1-9(2,3)11-6-5-8(7-11)10-4;1-8(2,3)10-6-5-9(4,11)7-10;1-9(2,3)10-6-4-8(11)5-7-10;1-9(2,3)10-6-4-5-8(11)7-10;1-8(2,3)10-5-4-7(9)6-10;1-8(2,3)9-4-6(10)7(11)5-9;1-8(2,3)9-5-4-7(10)6-9;1-7(2,3)8-4-6(9)5-8/h12,15H,4-11H2,1-3H3;11H,4-10H2,1-3H3;11H,5-10H2,1-4H3;10,13H,4-9H2,1-3H3;10,12H,5-9H2,1-4H3;8-9,11H,4-7H2,1-3H3;9H,6-8H2,1-5H3;9,11H,5-8H2,1-4H3;8-9H,4-7H2,1-3H3;8,10H,5-7H2,1-4H3;11H,5-7H2,1-4H3;2*8,11H,4-7H2,1-3H3;7H,4-6,9H2,1-3H3;6-7,10-11H,4-5H2,1-3H3;7,10H,4-6H2,1-3H3;6,9H,4-5H2,1-3H3
InChIKeyMSAOBIGBEWKLML-UHFFFAOYSA-N
MW2915.81 g/mol
LogP21.46
Rot. Bonds17

About 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine

1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine (PubChem CID 159654799) has the molecular formula C167H350FN27O10 and a molecular weight of 2915.81 g/mol. Its IUPAC name is 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine.

Molecular Properties

Compound Name1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine
PubChem CID159654799
Molecular FormulaC167H350FN27O10
Molecular Weight2915.81 g/mol
Exact Mass2913.77
IUPAC Name1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine
SMILESCC(C)(C)N1CC(O)C(O)C1.CC(C)(C)N1CC(O)C1.CC(C)(C)N1CC2CCC1C2.CC(C)(C)N1CCC(N)C1.CC(C)(C)N1CCC(N2CCOCC2)C1.CC(C)(C)N1CCC(NCCCF)C1.CC(C)(C)N1CCC(O)C1.CC(C)(C)N1CCC(O)CC1.CC(C)(C)N1CCC2CNCC21.CC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCN(C(=O)CC2CCCN2)CC1.CC1(O)CCN(C(C)(C)C)C1.CCCC1CCCN(C(C)(C)C)C1.CCNC1CCN(C(C)(C)C)C1.CN(C)C1CCN(C(C)(C)C)C1.CNC1CCN(C(C)(C)C)C1.COCCNC1CCN(C(C)(C)C)C1
InChIInChI=1S/C14H27N3O.C12H24N2O.C12H25N.C11H23FN2.C11H24N2O.C10H20N2.2C10H22N2.C10H19N.C9H20N2.3C9H19NO.C8H18N2.C8H17NO2.C8H17NO.C7H15NO/c1-14(2,3)17-9-7-16(8-10-17)13(18)11-12-5-4-6-15-12;1-12(2,3)14-5-4-11(10-14)13-6-8-15-9-7-13;1-5-7-11-8-6-9-13(10-11)12(2,3)4;1-11(2,3)14-8-5-10(9-14)13-7-4-6-12;1-11(2,3)13-7-5-10(9-13)12-6-8-14-4;1-10(2,3)12-5-4-8-6-11-7-9(8)12;1-10(2,3)12-7-6-9(8-12)11(4)5;1-5-11-9-6-7-12(8-9)10(2,3)4;1-10(2,3)11-7-8-4-5-9(11)6-8;1-9(2,3)11-6-5-8(7-11)10-4;1-8(2,3)10-6-5-9(4,11)7-10;1-9(2,3)10-6-4-8(11)5-7-10;1-9(2,3)10-6-4-5-8(11)7-10;1-8(2,3)10-5-4-7(9)6-10;1-8(2,3)9-4-6(10)7(11)5-9;1-8(2,3)9-5-4-7(10)6-9;1-7(2,3)8-4-6(9)5-8/h12,15H,4-11H2,1-3H3;11H,4-10H2,1-3H3;11H,5-10H2,1-4H3;10,13H,4-9H2,1-3H3;10,12H,5-9H2,1-4H3;8-9,11H,4-7H2,1-3H3;9H,6-8H2,1-5H3;9,11H,5-8H2,1-4H3;8-9H,4-7H2,1-3H3;8,10H,5-7H2,1-4H3;11H,5-7H2,1-4H3;2*8,11H,4-7H2,1-3H3;7H,4-6,9H2,1-3H3;6-7,10-11H,4-5H2,1-3H3;7,10H,4-6H2,1-3H3;6,9H,4-5H2,1-3H3
InChIKeyMSAOBIGBEWKLML-UHFFFAOYSA-N
XLogP21.46
TPSA340.14 Ų
H-Bond Donors14
H-Bond Acceptors36
Rotatable Bonds17
Heavy Atoms205
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002915.81
LogP ≤ 521.46
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine?
The IUPAC name of 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine (CID 159654799) is 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine.
What is the SMILES notation for 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine?
The canonical SMILES for 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine is CC(C)(C)N1CC(O)C(O)C1.CC(C)(C)N1CC(O)C1.CC(C)(C)N1CC2CCC1C2.CC(C)(C)N1CCC(N)C1.CC(C)(C)N1CCC(N2CCOCC2)C1.CC(C)(C)N1CCC(NCCCF)C1.CC(C)(C)N1CCC(O)C1.CC(C)(C)N1CCC(O)CC1.CC(C)(C)N1CCC2CNCC21.CC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCN(C(=O)CC2CCCN2)CC1.CC1(O)CCN(C(C)(C)C)C1.CCCC1CCCN(C(C)(C)C)C1.CCNC1CCN(C(C)(C)C)C1.CN(C)C1CCN(C(C)(C)C)C1.CNC1CCN(C(C)(C)C)C1.COCCNC1CCN(C(C)(C)C)C1.
What is the InChIKey of 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine?
The InChIKey is MSAOBIGBEWKLML-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H27N3O.C12H24N2O.C12H25N.C11H23FN2.C11H24N2O.C10H20N2.2C10H22N2.C10H19N.C9H20N2.3C9H19NO.C8H18N2.C8H17NO2.C8H17NO.C7H15NO/c1-14(2,3)17-9-7-16(8-10-17)13(18)11-12-5-4-6-15-12;1-12(2,3)14-5-4-11(10-14)13-6-8-15-9-7-13;1-5-7-11-8-6-9-13(10-11)12(2,3)4;1-11(2,3)14-8-5-10(9-14)13-7-4-6-12;1-11(2,3)13-7-5-10(9-13)12-6-8-14-4;1-10(2,3)12-5-4-8-6-11-7-9(8)12;1-10(2,3)12-7-6-9(8-12)11(4)5;1-5-11-9-6-7-12(8-9)10(2,3)4;1-10(2,3)11-7-8-4-5-9(11)6-8;1-9(2,3)11-6-5-8(7-11)10-4;1-8(2,3)10-6-5-9(4,11)7-10;1-9(2,3)10-6-4-8(11)5-7-10;1-9(2,3)10-6-4-5-8(11)7-10;1-8(2,3)10-5-4-7(9)6-10;1-8(2,3)9-4-6(10)7(11)5-9;1-8(2,3)9-5-4-7(10)6-9;1-7(2,3)8-4-6(9)5-8/h12,15H,4-11H2,1-3H3;11H,4-10H2,1-3H3;11H,5-10H2,1-4H3;10,13H,4-9H2,1-3H3;10,12H,5-9H2,1-4H3;8-9,11H,4-7H2,1-3H3;9H,6-8H2,1-5H3;9,11H,5-8H2,1-4H3;8-9H,4-7H2,1-3H3;8,10H,5-7H2,1-4H3;11H,5-7H2,1-4H3;2*8,11H,4-7H2,1-3H3;7H,4-6,9H2,1-3H3;6-7,10-11H,4-5H2,1-3H3;7,10H,4-6H2,1-3H3;6,9H,4-5H2,1-3H3.
What are the key properties of 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine?
1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine has a molecular weight of 2915.81 g/mol, XLogP of 21.46, 17 rotatable bonds, 14 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 1-tert-butyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole;2-tert-butyl-2-azabicyclo[2.2.1]heptane;1-tert-butylazetidin-3-ol;1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-N-ethylpyrrolidin-3-amine;1-tert-butyl-N-(3-fluoropropyl)pyrrolidin-3-amine;1-tert-butyl-N-(2-methoxyethyl)pyrrolidin-3-amine;1-tert-butyl-N-methylpyrrolidin-3-amine;1-tert-butyl-3-methylpyrrolidin-3-ol;1-(4-tert-butylpiperazin-1-yl)-2-pyrrolidin-2-ylethanone;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;1-tert-butyl-3-propylpiperidine;1-tert-butylpyrrolidin-3-amine;1-tert-butylpyrrolidine-3,4-diol;1-tert-butylpyrrolidin-3-ol;4-(1-tert-butylpyrrolidin-3-yl)morpholine is sourced from PubChem (CID 159654799), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).